These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7954588)

  • 1. Ischaemic preconditioning protects hypertrophied myocardium.
    Speechly-Dick ME; Baxter GF; Yellon DM
    Cardiovasc Res; 1994 Jul; 28(7):1025-9. PubMed ID: 7954588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemic preconditioning limits infarct size in the rat heart.
    Yellon DM; Alkhulaifi AM; Browne EE; Pugsley WB
    Cardiovasc Res; 1992 Oct; 26(10):983-7. PubMed ID: 1486593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts.
    Pantos CI; Davos CH; Carageorgiou HC; Varonos DV; Cokkinos DV
    Basic Res Cardiol; 1996; 91(6):444-9. PubMed ID: 8996629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning.
    Jenkins DP; Pugsley WB; Yellon DM
    J Mol Cell Cardiol; 1995 Aug; 27(8):1623-32. PubMed ID: 8523425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protection of ischaemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned.
    Yang XM; Arnoult S; Tsuchida A; Cope D; Thornton JD; Daly JF; Cohen MV; Downey JM
    Cardiovasc Res; 1993 Apr; 27(4):556-8. PubMed ID: 8324785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein.
    Liu Y; Downey JM
    Cardiovasc Res; 1993 Apr; 27(4):608-11. PubMed ID: 8324794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia.
    Moolman JA; Genade S; Tromp E; Opie LH; Lochner A
    S Afr Med J; 1997 Jun; 87 Suppl 3():C151-6. PubMed ID: 9254766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart--a protective additive to ischaemic preconditioning.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Feb; 29(2):269-74. PubMed ID: 7736505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models.
    Sandhu R; Diaz RJ; Wilson GJ
    Cardiovasc Res; 1993 Apr; 27(4):602-7. PubMed ID: 8324793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids.
    Li Y; Kloner RA
    Cardiovasc Res; 1992 Mar; 26(3):226-31. PubMed ID: 1423416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.
    Toombs CF; Moore TL; Shebuski RJ
    Cardiovasc Res; 1993 Apr; 27(4):617-22. PubMed ID: 8324795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
    Ebrahim Z; Yellon DM; Baxter GF
    Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism.
    Piacentini L; Wainwright CL; Parratt JR
    Cardiovasc Res; 1993 Apr; 27(4):674-80. PubMed ID: 8324804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
    Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
    BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic preconditioning by partial occlusion without intermittent reperfusion.
    Koning MM; Simonis LA; de Zeeuw S; Nieukoop S; Post S; Verdouw PD
    Cardiovasc Res; 1994 Aug; 28(8):1146-51. PubMed ID: 7954615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.